Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2019-12-21 2019-12-20
Drug Identification Number 02242471 02242471
Brand name DOSTINEX DOSTINEX
Common or Proper name Dostinex Dostinex
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CABERGOLINE CABERGOLINE
Strength(s) 0.5MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 8's 8's
ATC code G02CB G02CB
ATC description OTHER GYNECOLOGICALS OTHER GYNECOLOGICALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-10-08 2019-10-08
Estimated end date 2019-12-20 2019-12-20
Actual end date 2019-12-20 2019-12-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Distributed by Paladin. Limited inventory available and on preventative allocation. Distributed by Paladin. Limited inventory available and on preventative allocation.
Health Canada comments